<code id='135E647A5F'></code><style id='135E647A5F'></style>
    • <acronym id='135E647A5F'></acronym>
      <center id='135E647A5F'><center id='135E647A5F'><tfoot id='135E647A5F'></tfoot></center><abbr id='135E647A5F'><dir id='135E647A5F'><tfoot id='135E647A5F'></tfoot><noframes id='135E647A5F'>

    • <optgroup id='135E647A5F'><strike id='135E647A5F'><sup id='135E647A5F'></sup></strike><code id='135E647A5F'></code></optgroup>
        1. <b id='135E647A5F'><label id='135E647A5F'><select id='135E647A5F'><dt id='135E647A5F'><span id='135E647A5F'></span></dt></select></label></b><u id='135E647A5F'></u>
          <i id='135E647A5F'><strike id='135E647A5F'><tt id='135E647A5F'><pre id='135E647A5F'></pre></tt></strike></i>

          entertainment

          Wikipedia

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Industry veterans launch new biotech VC with $310M
          Industry veterans launch new biotech VC with $310M

          AdobeThreebiotechVCveterans,includingoneoftheco-foundersofradiopharmasuccessstoryRayzeBio,arelaunchi

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Bispecific antibodies are next new thing in cancer immunotherapy

          IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan